SANIMED’s global sales reached 15.819 million dinars (MD) on June 30, 2024, a decrease of 25% compared to the same period in 2023.
Local sales decreased from 9.980 MD on June 30, 2023 to 9.018 MD on June 30, 2024, a decrease of 10%. Export sales reached 6.801 MD compared to 10.990 MD for the same period in 2023, a decrease of 38%.
This decline is explained by supply difficulties and the delay in the start of the company’s financial restructuring,” says the company’s management.
They assure us that ‘this decline in export sales will be compensated by the company’s order book’. SANIMED is gradually catching up on the orders booked in the first quarter of 2024′.
As of June 30, 2024, production was 40% lower than in the same period of 2023. The company had made investments of approximately 0.266 MD as at June 30, 2024.
Bank liabilities amounted to 107.481 MD at June 30, 2024, compared to a total of 107.873 MD at December 31, 2023.
